ReviewFuture oncology (London, England)2012

Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.

Pravin T P Kaumaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.